NO922961L - Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav - Google Patents

Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav

Info

Publication number
NO922961L
NO922961L NO92922961A NO922961A NO922961L NO 922961 L NO922961 L NO 922961L NO 92922961 A NO92922961 A NO 92922961A NO 922961 A NO922961 A NO 922961A NO 922961 L NO922961 L NO 922961L
Authority
NO
Norway
Prior art keywords
cyclosporin
preparing
pharmaceutical composition
parts
procedures
Prior art date
Application number
NO92922961A
Other languages
English (en)
Norwegian (no)
Other versions
NO922961D0 (no
Inventor
Erno Orban
Laszlone Tomori
Maria Kuthy
Tibor Balogh
Laszlo Jaszlits
Imre Moravcsik
Istvan Kovacs
Istvanne Jusztin
Sandor Jancso
Erzsebet Takacs
Tamasne Kiss
Antalne Kovacs
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of NO922961D0 publication Critical patent/NO922961D0/no
Publication of NO922961L publication Critical patent/NO922961L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92922961A 1990-11-27 1992-07-27 Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav NO922961L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU907653A HU208491B (en) 1990-11-27 1990-11-27 Process for producing oral pharmaceutical composition containing cyclosporin
PCT/HU1991/000050 WO1992009299A1 (en) 1990-11-27 1991-11-27 Oral pharmaceutical composition containing cyclosporin and process for preparing same

Publications (2)

Publication Number Publication Date
NO922961D0 NO922961D0 (no) 1992-07-27
NO922961L true NO922961L (no) 1992-09-23

Family

ID=10972318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922961A NO922961L (no) 1990-11-27 1992-07-27 Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav

Country Status (18)

Country Link
US (1) US5430017A (xx)
EP (1) EP0512109B1 (xx)
JP (1) JPH082795B2 (xx)
AT (1) ATE129898T1 (xx)
AU (1) AU651154B2 (xx)
CA (1) CA2072983A1 (xx)
CS (1) CS230492A3 (xx)
DE (1) DE69114476T2 (xx)
DK (1) DK0512109T3 (xx)
FI (1) FI923385A (xx)
HU (1) HU208491B (xx)
IL (1) IL100162A (xx)
MX (1) MX9102243A (xx)
NO (1) NO922961L (xx)
NZ (1) NZ240762A (xx)
PT (1) PT99623A (xx)
WO (1) WO1992009299A1 (xx)
ZA (1) ZA919352B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
AU764599B2 (en) * 1995-08-25 2003-08-21 Sangstat Medical Corporation Oral cyclosporin formulations
MX9702809A (es) * 1995-08-25 1998-02-28 Sangstat Medical Corp Formulaciones orales de ciclosporina.
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
SK285019B6 (sk) 1997-01-30 2006-04-06 Novartis Ag Tvrdá želatínová tobolka
IL131609A0 (en) * 1997-03-12 2001-01-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
IL143604A0 (en) 1998-12-30 2002-04-21 Dexcel Ltd Dispersable concentrate for the delivery of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE290460C (xx) *
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
CA1323306C (en) * 1987-03-05 1993-10-19 Mircea C. Popescu Pharmacological agent-lipid solution preparation
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
BE1003009A5 (fr) * 1989-02-09 1991-10-22 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines.
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine

Also Published As

Publication number Publication date
MX9102243A (es) 1992-07-08
ZA919352B (en) 1992-09-30
FI923385A0 (fi) 1992-07-27
DE69114476D1 (de) 1995-12-14
DK0512109T3 (da) 1995-12-11
AU8944091A (en) 1992-06-25
WO1992009299A1 (en) 1992-06-11
DE69114476T2 (de) 1996-04-18
EP0512109A1 (en) 1992-11-11
HUT60929A (en) 1992-11-30
CS230492A3 (en) 1992-12-16
NZ240762A (en) 1993-05-26
PT99623A (pt) 1992-12-31
EP0512109B1 (en) 1995-11-08
CA2072983A1 (en) 1992-05-28
NO922961D0 (no) 1992-07-27
AU651154B2 (en) 1994-07-14
JPH082795B2 (ja) 1996-01-17
HU907653D0 (en) 1991-06-28
HU208491B (en) 1993-11-29
ATE129898T1 (de) 1995-11-15
IL100162A (en) 1995-11-27
US5430017A (en) 1995-07-04
IL100162A0 (en) 1992-08-18
FI923385A (fi) 1992-07-27
JPH05503306A (ja) 1993-06-03

Similar Documents

Publication Publication Date Title
NO922961D0 (no) Oral farmasoeytisk sammensetning inneholdende cyklosporin og fremgangsmaate ved fremstilling derav
EP0368388A3 (en) 3-Piperidinyl-1,2-benzisoxazoles
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
ES8202543A1 (es) Procedimiento para la preparacion de sulfonilureas
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
HUP0300836A2 (hu) Taxánokat tartalmazó szájon át beadható gyógyszerkészítmények és ezek alkalmazása
FI832355A0 (fi) 9-(2-hydroxyetoximetyl)guanidin-derivat
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
EP0317281A3 (en) Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydrochloride and processes for preparing them
AU8261787A (en) Medicaments for the treatment of depression
PT77309B (de) Isochinolinderivate verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
NO905378L (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazinderivater
PT75492A (de) Sulfonylharnstoffe verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
CA2162919A1 (en) Rectal Compositions
DK1061938T3 (da) Orale sammensætninger med cytotoksiske proteiner i lav dosis
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
WO2002041879A3 (en) Antidiabetic compositions containing a biguanide and a sulfonamide
ATE75619T1 (de) Bestaendige therapeutische zusammensetzungen, basierend auf hydrophobem pflanzlichem oel und verfahren zu ihrer herstellung.
YU186691A (sh) Postupak za dobijanje oralnog farmaceutskog preparata koji sadrži ciklosporin
ATE92037T1 (de) Kardiovaskulaer aktive verbindungen.